X-linked Moesin Associated Immunodeficiency

Launched by INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, FRANCE · Feb 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a rare condition called X-linked Moesin Associated Immunodeficiency (X-MAID), which affects the immune system and can lead to frequent infections. The trial aims to better understand how this condition presents in patients, establish clearer treatment guidelines, and provide the best care possible for those affected. The researchers are particularly interested in male patients who have a specific mutation in the MOESIN gene, which is known to be linked to this immune deficiency.

Eligible participants are male patients with a mutation in the MOESIN gene and who agree to share their health information for the study. Those who join the trial will help researchers gather important data that could improve how doctors diagnose and treat this condition. The trial is currently recruiting participants, so if you or someone you know fits the criteria, it could be an opportunity to contribute to valuable medical research while receiving expert care.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Male patient with a mutation in the MOESIN gene (MSN)
• • No objection to the collection of personal health data
• Exclusion Criteria:
• • -